Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caudal dexmedetomidine plus bupivacaine for suppression of hernial sac traction response in children undergoing unilateral inguinal hernia repair
ChiCTR-TRC-11001785Phase 4Completed
- Sponsor
- Wuhan Women and Children's Health Care Center
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in inguinal hernia comparing Caudal bupivacaine with Caudal bupivacaine + dexmedetomidine (2 arms). Primary endpoints: Heart rate and Systolic arterial pressure. Started Dec 2010; status: completed.
02
Drugs
dexmedetomidinebupivacaine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on ChiCTR-TRC-11001785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001785.